Empagliflozin vs Upadacitinib

## Empagliflozin vs Upadacitinib: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Upadacitinib**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Upadacitinib**: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Upadacitinib — 9-14 hours.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Upadacitinib — C17H19F3N6O.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Upadacitinib — 380.3700 g/mol.

**Type**: Empagliflozin — Small molecule; Upadacitinib — Small molecule.